Not a good buy right now: the stock is in a clear bearish trend (SMA_200 > SMA_20 > SMA_5) and trading at/just below key support (S1 ~1.771) with weakening fundamentals.
Insider activity is a major red flag: insiders are selling and the selling amount increased ~294.54% over the last month.
No supportive Intellectia signals today, and pattern-based forward odds point to downside over the next week/month.
Trend: Bearish structure with moving averages stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating the primary trend remains down.
Momentum: MACD histogram is positive (0.0924) but positively contracting, implying upside momentum is fading rather than strengthening.
RSI (6): 31.769 (near the lower end of neutral/approaching oversold), which can support short bounces, but it is not a strong reversal confirmation by itself.
Key levels: Price 1.73 is slightly below S1 (1.771). If it fails to reclaim/hold that area, next notable support is S2 (0.735). Overhead resistance remains far (pivot ~3.448; R1 ~5.125), showing heavy technical damage.
Probabilistic trend read: Similar-pattern stats suggest +5.16% next day potential, but -6.97% next week and -5.14% next month—net bearish for an impatient buyer.
Positive Catalysts
is above the current price (~1.73).
Neutral/Negative Catalysts
if support fails.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 7.984M, -12.02% YoY (contraction).
Net income: -2.68M (loss), down -0.37% YoY (still meaningfully negative).
2025-11-07: Benchmark downgraded to Speculative Buy from Buy and cut price target to $2 from $6 after a "really tough 3Q25 print."
Wall Street pro view (pros/cons):
Pros: Analyst believes liquidity is likely sufficient and shares could be meaningfully higher next year if management executes through the downturn.
Cons: The downgrade and large target cut reflect materially worse near-term fundamentals/visibility; the thesis is now explicitly high-risk/speculative rather than a standard buy.
Politicians / influential figures: No recent congress trading data available in the last 90 days.
Wall Street analysts forecast DRCT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DRCT is 2 USD with a low forecast of 2 USD and a high forecast of 2 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast DRCT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DRCT is 2 USD with a low forecast of 2 USD and a high forecast of 2 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 1.590
Low
2
Averages
2
High
2
Current: 1.590
Low
2
Averages
2
High
2
Benchmark
Buy -> Speculative Buy
downgrade
$6 -> $2
AI Analysis
2025-11-07
Reason
Benchmark
Price Target
$6 -> $2
AI Analysis
2025-11-07
downgrade
Buy -> Speculative Buy
Reason
Benchmark downgraded Direct Digital to Speculative Buy from Buy with a price target of $2, down from $6, after what the firm calls "a really tough 3Q25 print." The company should have enough liquidity, so "they are still in the race," says the analyst, who contends shares "could be meaningfully higher by this time next year" if this management team "can weather this last storm."
